TY - JOUR AU - Phillips, M. A. AU - Burrows, J. N. AU - Manyando, C. AU - Huijsduijnen, R. H. AU - Voorhis, W. C. AU - Wells, T. N. C. PY - 2017 DA - 2017// TI - Malaria JO - Nat Rev Dis Primers. VL - 3 UR - https://doi.org/10.1038/nrdp.2017.50 DO - 10.1038/nrdp.2017.50 ID - Phillips2017 ER - TY - STD TI - WHO. World malaria report 2018. Geneva: World Health Organization; 2018. https://www.who.int/malaria/publications/world_malaria_report/en/. Accessed 17 Mar 2019. UR - https://www.who.int/malaria/publications/world_malaria_report/en/ ID - ref2 ER - TY - JOUR AU - Rosenthal, P. J. AU - John, C. C. AU - Rabinovich, N. R. PY - 2019 DA - 2019// TI - Malaria: how are we doing and how can we do better? JO - Am J Trop Med Hyg VL - 100 UR - https://doi.org/10.4269/ajtmh.18-0997 DO - 10.4269/ajtmh.18-0997 ID - Rosenthal2019 ER - TY - JOUR AU - Pieper, K. AU - Tan, J. AU - Piccoli, L. AU - Foglierini, M. AU - Barbieri, S. AU - Chen, Y. PY - 2017 DA - 2017// TI - Public antibodies to malaria antigens generated by two LAIR1 insertion modalities JO - Nature VL - 548 UR - https://doi.org/10.1038/nature23670 DO - 10.1038/nature23670 ID - Pieper2017 ER - TY - JOUR AU - Tan, J. AU - Sack, B. K. AU - Oyen, D. AU - Zenklusen, I. AU - Piccoli, L. AU - Barbieri, S. PY - 2018 DA - 2018// TI - A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein JO - Nat Med VL - 24 UR - https://doi.org/10.1038/nm.4513 DO - 10.1038/nm.4513 ID - Tan2018 ER - TY - JOUR AU - Macintyre, F. AU - Ramachandruni, H. AU - Burrows, J. N. AU - Holm, R. AU - Thomas, A. AU - Mohrle, J. J. PY - 2018 DA - 2018// TI - Injectable anti-malarials revisited: discovery and development of new agents to protect against malaria JO - Malar J. VL - 17 UR - https://doi.org/10.1186/s12936-018-2549-1 DO - 10.1186/s12936-018-2549-1 ID - Macintyre2018 ER - TY - STD TI - Workman D. Drugs and medicine exports by country. http://www.worldstopexports.com/drugs-medicine-exports-country/. Accessed 17 Mar 2019. UR - http://www.worldstopexports.com/drugs-medicine-exports-country/ ID - ref7 ER - TY - JOUR AU - Burrows, J. N. AU - Duparc, S. AU - Gutteridge, W. E. AU - Huijsduijnen, R. H. AU - Kaszubska, W. AU - Macintyre, F. PY - 2017 DA - 2017// TI - New developments in anti-malarial target candidate and product profiles JO - Malar J VL - 16 UR - https://doi.org/10.1186/s12936-016-1675-x DO - 10.1186/s12936-016-1675-x ID - Burrows2017 ER - TY - JOUR AU - Burrows, J. AU - Slater, H. AU - Macintyre, F. AU - Rees, S. AU - Thomas, A. AU - Okumu, F. PY - 2018 DA - 2018// TI - A discovery and development roadmap for new endectocidal transmission-blocking agents in malaria JO - Malar J. VL - 17 UR - https://doi.org/10.1186/s12936-018-2598-5 DO - 10.1186/s12936-018-2598-5 ID - Burrows2018 ER - TY - JOUR PY - 2017 DA - 2017// TI - malERA: an updated research agenda for diagnostics, drugs, vaccines, and vector control in malaria elimination and eradication JO - PLoS Med. VL - 14 UR - https://doi.org/10.1371/journal.pmed.1002455 DO - 10.1371/journal.pmed.1002455 ID - ref10 ER - TY - JOUR AU - Schramm, B. AU - Valeh, P. AU - Baudin, E. AU - Mazinda, C. S. AU - Smith, R. AU - Pinoges, L. PY - 2013 DA - 2013// TI - Tolerability and safety of artesunate-amodiaquine and artemether–lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia JO - Malar J. VL - 12 UR - https://doi.org/10.1186/1475-2875-12-250 DO - 10.1186/1475-2875-12-250 ID - Schramm2013 ER - TY - JOUR AU - Mishra, N. AU - Kaitholia, K. AU - Srivastava, B. AU - Shah, N. K. AU - Narayan, J. P. AU - Dev, V. PY - 2014 DA - 2014// TI - Declining efficacy of artesunate plus sulphadoxine–pyrimethamine in northeastern India JO - Malar J. VL - 13 UR - https://doi.org/10.1186/1475-2875-13-284 DO - 10.1186/1475-2875-13-284 ID - Mishra2014 ER - TY - JOUR AU - Voorhis, W. C. AU - Hooft van Huijsduijnen, R. AU - Wells, T. N. C. PY - 2015 DA - 2015// TI - Profile of William C. Campbell, Satoshi Ōmura, and Youyou Tu, 2015 Nobel Laureates in Physiology or Medicine JO - Proc Natl Acad Sci USA VL - 2015 UR - https://doi.org/10.1073/pnas.1520952112 DO - 10.1073/pnas.1520952112 ID - Voorhis2015 ER - TY - JOUR AU - Ashley, E. A. AU - Pyae Phyo, A. AU - Woodrow, C. J. PY - 2018 DA - 2018// TI - Malaria JO - Lancet. VL - 391 UR - https://doi.org/10.1016/S0140-6736(18)30324-6 DO - 10.1016/S0140-6736(18)30324-6 ID - Ashley2018 ER - TY - JOUR AU - Vennerstrom, J. L. AU - Arbe-Barnes, S. AU - Brun, R. AU - Charman, S. A. AU - Chiu, F. C. AU - Chollet, J. PY - 2004 DA - 2004// TI - Identification of an antimalarial synthetic trioxolane drug development candidate JO - Nature VL - 430 UR - https://doi.org/10.1038/nature02779 DO - 10.1038/nature02779 ID - Vennerstrom2004 ER - TY - JOUR AU - Valecha, N. AU - Savargaonkar, D. AU - Srivastava, B. AU - Rao, B. H. AU - Tripathi, S. K. AU - Gogtay, N. PY - 2016 DA - 2016// TI - Comparison of the safety and efficacy of fixed-dose combination of arterolane maleate and piperaquine phosphate with chloroquine in acute, uncomplicated Plasmodium vivax malaria: a phase III, multicentric, open-label study JO - Malar J. VL - 15 UR - https://doi.org/10.1186/s12936-016-1084-1 DO - 10.1186/s12936-016-1084-1 ID - Valecha2016 ER - TY - JOUR AU - Charman, S. A. AU - Arbe-Barnes, S. AU - Bathurst, I. C. AU - Brun, R. AU - Campbell, M. AU - Charman, W. N. PY - 2011 DA - 2011// TI - Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria JO - Proc Natl Acad Sci USA VL - 108 UR - https://doi.org/10.1073/pnas.1015762108 DO - 10.1073/pnas.1015762108 ID - Charman2011 ER - TY - JOUR AU - Kim, H. S. AU - Hammill, J. T. AU - Guy, R. K. PY - 2017 DA - 2017// TI - Seeking the elusive long-acting ozonide: discovery of Artefenomel (OZ439) JO - J Med Chem VL - 60 UR - https://doi.org/10.1021/acs.jmedchem.7b00299 DO - 10.1021/acs.jmedchem.7b00299 ID - Kim2017 ER - TY - JOUR AU - Möhrle, J. J. AU - Duparc, S. AU - Siethoff, C. AU - Giersbergen, P. L. AU - Craft, J. C. AU - Arbe-Barnes, S. PY - 2013 DA - 2013// TI - First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarials JO - Br J Clin Pharmacol VL - 75 ID - Möhrle2013 ER - TY - JOUR AU - McCarthy, J. S. AU - Baker, M. AU - O’Rourke, P. AU - Marquart, L. AU - Griffin, P. AU - Huijsduijnen, R. H. PY - 2016 DA - 2016// TI - Efficacy of OZ439 (artefenomel) against early Plasmodium falciparum blood-stage malaria infection in healthy volunteers JO - J Antimicrob Chemother VL - 71 UR - https://doi.org/10.1093/jac/dkw174 DO - 10.1093/jac/dkw174 ID - McCarthy2016 ER - TY - JOUR AU - Ariey, F. AU - Witkowski, B. AU - Amaratunga, C. AU - Beghain, J. AU - Langlois, A. C. AU - Khim, N. PY - 2014 DA - 2014// TI - A molecular marker of artemisinin-resistant Plasmodium falciparum malaria JO - Nature VL - 505 UR - https://doi.org/10.1038/nature12876 DO - 10.1038/nature12876 ID - Ariey2014 ER - TY - JOUR AU - Haldar, K. AU - Bhattacharjee, S. AU - Safeukui, I. PY - 2018 DA - 2018// TI - Drug resistance in Plasmodium JO - Nat Rev Microbiol VL - 16 UR - https://doi.org/10.1038/nrmicro.2017.161 DO - 10.1038/nrmicro.2017.161 ID - Haldar2018 ER - TY - JOUR PY - 2019 DA - 2019// TI - Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments—a WWARN individual patient data meta-analysis JO - BMC Med. VL - 17 UR - https://doi.org/10.1186/s12916-018-1207-3 DO - 10.1186/s12916-018-1207-3 ID - ref23 ER - TY - JOUR AU - Straimer, J. AU - Gnadig, N. F. AU - Stokes, B. H. AU - Ehrenberger, M. AU - Crane, A. A. AU - Fidock, D. A. PY - 2017 DA - 2017// TI - Plasmodium falciparum K13 mutations differentially impact ozonide susceptibility and parasite fitness in vitro JO - MBio. VL - 8 UR - https://doi.org/10.1128/mBio.00172-17 DO - 10.1128/mBio.00172-17 ID - Straimer2017 ER - TY - JOUR AU - Baumgartner, F. AU - Jourdan, J. AU - Scheurer, C. AU - Blasco, B. AU - Campo, B. AU - Maser, P. PY - 2017 DA - 2017// TI - In vitro activity of anti-malarial ozonides against an artemisinin-resistant isolate JO - Malar J. VL - 16 UR - https://doi.org/10.1186/s12936-017-1696-0 DO - 10.1186/s12936-017-1696-0 ID - Baumgartner2017 ER - TY - JOUR AU - Wells, T. N. C. AU - Huijsduijnen, R. H. AU - Voorhis, W. C. PY - 2015 DA - 2015// TI - Malaria medicines: a glass half full? JO - Nat Rev Drug Discov. VL - 14 UR - https://doi.org/10.1038/nrd4573 DO - 10.1038/nrd4573 ID - Wells2015 ER - TY - JOUR AU - Meister, S. AU - Plouffe, D. M. AU - Kuhen, K. L. AU - Bonamy, G. M. AU - Wu, T. AU - Barnes, S. W. PY - 2011 DA - 2011// TI - Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery JO - Science VL - 334 UR - https://doi.org/10.1126/science.1211936 DO - 10.1126/science.1211936 ID - Meister2011 ER - TY - JOUR AU - Gamo, F. J. AU - Sanz, L. M. AU - Vidal, J. AU - Cozar, C. AU - Alvarez, E. AU - Lavandera, J. L. PY - 2010 DA - 2010// TI - Thousands of chemical starting points for antimalarial lead identification JO - Nature VL - 465 UR - https://doi.org/10.1038/nature09107 DO - 10.1038/nature09107 ID - Gamo2010 ER - TY - JOUR AU - Guiguemde, W. A. AU - Shelat, A. A. AU - Bouck, D. AU - Duffy, S. AU - Crowther, G. J. AU - Davis, P. H. PY - 2010 DA - 2010// TI - Chemical genetics of Plasmodium falciparum JO - Nature VL - 465 UR - https://doi.org/10.1038/nature09099 DO - 10.1038/nature09099 ID - Guiguemde2010 ER - TY - JOUR AU - Avery, V. M. AU - Bashyam, S. AU - Burrows, J. N. AU - Duffy, S. AU - Papadatos, G. AU - Puthukkuti, S. PY - 2014 DA - 2014// TI - Screening and hit evaluation of a chemical library against blood-stage Plasmodium falciparum JO - Malar J. VL - 13 UR - https://doi.org/10.1186/1475-2875-13-190 DO - 10.1186/1475-2875-13-190 ID - Avery2014 ER - TY - JOUR AU - Rottmann, M. AU - McNamara, C. AU - Yeung, B. K. AU - Lee, M. C. AU - Zou, B. AU - Russell, B. PY - 2010 DA - 2010// TI - Spiroindolones, a potent compound class for the treatment of malaria JO - Science VL - 329 UR - https://doi.org/10.1126/science.1193225 DO - 10.1126/science.1193225 ID - Rottmann2010 ER - TY - JOUR AU - White, N. J. AU - Pukrittayakamee, S. AU - Phyo, A. P. AU - Rueangweerayut, R. AU - Nosten, F. AU - Jittamala, P. PY - 2014 DA - 2014// TI - Spiroindolone KAE609 for falciparum and vivax malaria JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1315860 DO - 10.1056/NEJMoa1315860 ID - White2014 ER - TY - JOUR AU - Koller, R. AU - Mombo-Ngoma, G. AU - Grobusch, M. P. PY - 2018 DA - 2018// TI - The early pre-clinical and clinical development of ganaplacide (KAF156), a novel antimalarial compound JO - Expert Opin Investig Drugs VL - 27 UR - https://doi.org/10.1080/13543784.2018.1524871 DO - 10.1080/13543784.2018.1524871 ID - Koller2018 ER - TY - JOUR AU - Leong, F. J. AU - Jain, J. P. AU - Feng, Y. AU - Goswami, B. AU - Stein, D. S. PY - 2018 DA - 2018// TI - A phase 1 evaluation of the pharmacokinetic/pharmacodynamic interaction of the anti-malarial agents KAF156 and piperaquine JO - Malar J. VL - 17 UR - https://doi.org/10.1186/s12936-017-2162-8 DO - 10.1186/s12936-017-2162-8 ID - Leong2018 ER - TY - JOUR AU - Leong, F. J. AU - Zhao, R. AU - Zeng, S. AU - Magnusson, B. AU - Diagana, T. T. AU - Pertel, P. PY - 2014 DA - 2014// TI - A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel Imidazolopiperazine KAF156 to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers JO - Antimicrob Agents Chemother VL - 58 UR - https://doi.org/10.1128/AAC.03478-14 DO - 10.1128/AAC.03478-14 ID - Leong2014 ER - TY - JOUR AU - White, N. J. AU - Duong, T. T. AU - Uthaisin, C. AU - Nosten, F. AU - Phyo, A. P. AU - Hanboonkunupakarn, B. PY - 2016 DA - 2016// TI - Antimalarial activity of KAF156 in falciparum and vivax malaria JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMoa1602250 DO - 10.1056/NEJMoa1602250 ID - White2016 ER - TY - JOUR AU - Voorhis, W. C. AU - Adams, J. H. AU - Adelfio, R. AU - Ahyong, V. AU - Akabas, M. H. AU - Alano, P. PY - 2016 DA - 2016// TI - Open source drug discovery with the Malaria Box compound collection for neglected diseases and beyond JO - PLoS Pathog VL - 12 UR - https://doi.org/10.1371/journal.ppat.1005763 DO - 10.1371/journal.ppat.1005763 ID - Voorhis2016 ER - TY - JOUR AU - Preston, S. AU - Jiao, Y. AU - Jabbar, A. AU - McGee, S. L. AU - Laleu, B. AU - Willis, P. PY - 2016 DA - 2016// TI - Screening of the ‘Pathogen Box’ identifies an approved pesticide with major anthelmintic activity against the barber’s pole worm JO - Int J Parasitol Drugs Drug Resist. VL - 6 UR - https://doi.org/10.1016/j.ijpddr.2016.07.004 DO - 10.1016/j.ijpddr.2016.07.004 ID - Preston2016 ER - TY - JOUR AU - Veale, C. PY - 2019 DA - 2019// TI - Unpacking the pathogen box—an open source tool for fighting neglected tropical diseases JO - ChemMedChem VL - 14 UR - https://doi.org/10.1002/cmdc.201800755 DO - 10.1002/cmdc.201800755 ID - Veale2019 ER - TY - JOUR AU - Boss, C. AU - Aissaoui, H. AU - Amaral, N. AU - Bauer, A. AU - Bazire, S. AU - Binkert, C. PY - 2016 DA - 2016// TI - Discovery and characterization of ACT-451840: an antimalarial drug with a novel mechanism of action JO - ChemMedChem VL - 11 UR - https://doi.org/10.1002/cmdc.201600298 DO - 10.1002/cmdc.201600298 ID - Boss2016 ER - TY - JOUR AU - Bihan, A. AU - Kanter, R. AU - Angulo-Barturen, I. AU - Binkert, C. AU - Boss, C. AU - Brun, R. PY - 2016 DA - 2016// TI - Characterization of novel antimalarial compound ACT-451840: preclinical assessment of activity and dose-efficacy modeling JO - PLoS Med. VL - 13 UR - https://doi.org/10.1371/journal.pmed.1002138 DO - 10.1371/journal.pmed.1002138 ID - Bihan2016 ER - TY - JOUR AU - Bruderer, S. AU - Hurst, N. AU - Kanter, R. AU - Miraval, T. AU - Pfeifer, T. AU - Donazzolo, Y. PY - 2014 DA - 2014// TI - First-in-man safety, tolerability, and pharmacokinetics of ACT-451840, a new chemical entity with antimalarial activity JO - Antimicrob Agents Chemother VL - 59 UR - https://doi.org/10.1128/AAC.04125-14 DO - 10.1128/AAC.04125-14 ID - Bruderer2014 ER - TY - JOUR AU - Krause, A. AU - Dingemanse, J. AU - Mathis, A. AU - Marquart, L. AU - Mohrle, J. J. AU - McCarthy, J. S. PY - 2016 DA - 2016// TI - Pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of Actelion-451840 in an induced blood stage malaria study in healthy subjects JO - Br J Clin Pharmacol VL - 82 UR - https://doi.org/10.1111/bcp.12962 DO - 10.1111/bcp.12962 ID - Krause2016 ER - TY - JOUR AU - Paquet, T. AU - Manach, C. AU - Cabrera, D. G. AU - Younis, Y. AU - Henrich, P. P. AU - Abraham, T. S. PY - 2017 DA - 2017// TI - Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase JO - Sci Transl Med. VL - 9 UR - https://doi.org/10.1126/scitranslmed.aad9735 DO - 10.1126/scitranslmed.aad9735 ID - Paquet2017 ER - TY - JOUR AU - Ghidelli-Disse, S. AU - Lafuente-Monasterio, M. J. AU - Waterson, D. AU - Witty, M. AU - Younis, Y. AU - Paquet, T. PY - 2014 DA - 2014// TI - Identification of Plasmodium PI4 kinase as target of MMV390048 by chemoproteomics JO - Malar J. VL - 13 UR - https://doi.org/10.1186/1475-2875-13-S1-P38 DO - 10.1186/1475-2875-13-S1-P38 ID - Ghidelli-Disse2014 ER - TY - JOUR AU - Nchinda, A. T. AU - Manach, C. AU - Paquet, T. AU - Gonzalez Cabrera, D. AU - Wicht, K. J. AU - Brunschwig, C. PY - 2018 DA - 2018// TI - Identification of fast-acting 2,6-disubstituted imidazopyridines that are efficacious in the in vivo humanized Plasmodium falciparum NODscidIL2Rg−/− mouse model of malaria JO - J Med Chem VL - 61 UR - https://doi.org/10.1021/acs.jmedchem.8b00382 DO - 10.1021/acs.jmedchem.8b00382 ID - Nchinda2018 ER - TY - JOUR AU - Jaramillo-Ochoa, R. AU - Sippy, R. AU - Farrell, D. F. AU - Cueva-Aponte, C. AU - Beltran-Ayala, E. AU - Gonzaga, J. L. PY - 2019 DA - 2019// TI - Effects of political instability in Venezuela on malaria resurgence at Ecuador-Peru border, 2018 JO - Emerg Infect Dis VL - 25 UR - https://doi.org/10.3201/eid2504.181355 DO - 10.3201/eid2504.181355 ID - Jaramillo-Ochoa2019 ER -